Deceleration in the rate of keratinocyte cancers and precancerous lesions during programmed death‐1 inhibition therapy for advanced melanoma, with recrudescence on discontinuation

Early View

Letter to the Editor

L. Roche,

Corresponding Author

L. Roche

Departments of Dermatology,, St Vincent's Healthcare Group Strategic Skin Cancer Network, St Vincent's University Hospital, Dublin, Ireland

Search for more papers by this authorB. Moriarty,

B. Moriarty

Departments of Dermatology,, St Vincent's Healthcare Group Strategic Skin Cancer Network, St Vincent's University Hospital, Dublin, Ireland

Search for more papers by this authorA. Fabre,

A. Fabre

Histopathology, St Vincent's Healthcare Group Strategic Skin Cancer Network, St Vincent's University Hospital, Dublin, Ireland

Search for more papers by this authorJ. Crowne,

J. Crowne

Medical Oncology, St Vincent's Healthcare Group Strategic Skin Cancer Network, St Vincent's University Hospital, Dublin, Ireland

Search for more papers by this authorA. Lally,

A. Lally

Departments of Dermatology,, St Vincent's Healthcare Group Strategic Skin Cancer Network, St Vincent's University Hospital, Dublin, Ireland

Search for more papers by this author PDFPDF Please review our Terms and Conditions of Use and check box below to share full-text version of article.

I have read and accept the Wiley Online Library Terms and Conditions of Use

Shareable Link

Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Share a link

Share on

No abstract is available for this article.

留言 (0)

沒有登入
gif